FDA awards breakthrough therapy designation to IMMU-132 for triple-negative breast cancer Feb. 8, 2016
Mersana and Takeda expand partnership to advance development of Fleximer-based ADC therapies Feb. 4, 2016
Targovax submits a study protocol for ONCOS-102 trial to the regulatory authorities in Spain Feb. 3, 2016
RSS